Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The mammalian Hippo pathway: regulation and function of YAP1 and TAZ
Manami Kodaka, Yutaka Hata
Cellular and Molecular Life Sciences (2014) Vol. 72, Iss. 2, pp. 285-306
Open Access | Times Cited: 100

Showing 1-25 of 100 citing articles:

Role of Merlin/NF2 inactivation in tumor biology
Alejandra M. Petrilli, Cristina Fernández‐Valle
Oncogene (2015) Vol. 35, Iss. 5, pp. 537-548
Open Access | Times Cited: 393
YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers
Claudia Stein, Anaïs F. Bardet, Guglielmo Roma, et al.
PLoS Genetics (2015) Vol. 11, Iss. 8, pp. e1005465-e1005465
Open Access | Times Cited: 370
The novel potent TEAD inhibitor, K-975, inhibits YAP1/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma.
Ayumi Kaneda, Toshihiro Seike, Tomohiro Danjo, et al.
American Journal of Cancer Research (2020) Vol. 10, Iss. 12, pp. 4399-4415
Closed Access | Times Cited: 115
Identification of Hub Genes and Key Pathways Associated With Bipolar Disorder Based on Weighted Gene Co-expression Network Analysis
Yang Liu, Hui-Yun Gu, Jie Zhu, et al.
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 102
The MST/Hippo Pathway and Cell Death: A Non-Canonical Affair
Emma Fallahi, Niamh A. O’Driscoll, David Matallanas
Genes (2016) Vol. 7, Iss. 6, pp. 28-28
Open Access | Times Cited: 88
Hippo pathway: Regulation, deregulation and potential therapeutic targets in cancer
Suman Mohajan, Praveen Kumar Jaiswal, Mousa Vatanmakarian, et al.
Cancer Letters (2021) Vol. 507, pp. 112-123
Open Access | Times Cited: 84
Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux transporter-mediated multidrug resistance in cancer
Pradhapsingh Bharathiraja, Priya Yadav, Andaleeb Sajid, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101004-101004
Open Access | Times Cited: 42
Evidence of cancer‐promoting roles for AMPK and related kinases
Tiziana Monteverde, Nathiya Muthalagu, Jennifer Port, et al.
FEBS Journal (2015) Vol. 282, Iss. 24, pp. 4658-4671
Open Access | Times Cited: 84
The Hippo pathway in colorectal cancer
Piotr Wierzbicki, Agnieszka Rybarczyk
Folia Histochemica et Cytobiologica (2015) Vol. 53, Iss. 2, pp. 105-119
Open Access | Times Cited: 82
RETRACTED ARTICLE: Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis
Huan Yan, Hong Li, Pengyun Li, et al.
Journal of Experimental & Clinical Cancer Research (2018) Vol. 37, Iss. 1
Open Access | Times Cited: 66
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK/PI3K induced malignant growth
Marie Mayrhofer, Victor Gourain, Markus Reischl, et al.
Disease Models & Mechanisms (2016)
Open Access | Times Cited: 61
The YAP1 Signaling Inhibitors, Verteporfin and CA3, Suppress the Mesothelioma Cancer Stem Cell Phenotype
Sivaveera Kandasamy, Gautam Adhikary, Ellen A. Rorke, et al.
Molecular Cancer Research (2019) Vol. 18, Iss. 3, pp. 343-351
Open Access | Times Cited: 55
The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease
Zhuo Xie, Ying Wang, Guang Yang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 52
YAP and the Hippo pathway in pediatric cancer
Atif Ahmed, Abdalla D. Mohamed, Melissa Gener, et al.
Molecular & Cellular Oncology (2017) Vol. 4, Iss. 3, pp. e1295127-e1295127
Open Access | Times Cited: 55
Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance
Dong‐Yu Wang, Yanan Wu, Junqi Huang, et al.
Chinese Journal of Cancer (2016) Vol. 35, Iss. 1
Open Access | Times Cited: 52
Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1
Andrew Fesler, Hua Liu, Jingfang Ju
Oncotarget (2017) Vol. 9, Iss. 2, pp. 2367-2383
Open Access | Times Cited: 51
Discovery of a Small Molecule to Increase Cardiomyocytes and Protect the Heart After Ischemic Injury
Hironori Hara, Norifumi Takeda, Masaki Kondo, et al.
JACC Basic to Translational Science (2018) Vol. 3, Iss. 5, pp. 639-653
Open Access | Times Cited: 47
ROCK2 deprivation leads to the inhibition of tumor growth and metastatic potential in osteosarcoma cells through the modulation of YAP activity
Cinzia Zucchini, Maria Cristina Manara, Camilla Cristalli, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 45
YAP promotes epithelial mesenchymal transition by upregulating Slug expression in human colorectal cancer cells
Dan Cheng, Lan Jin, Chen Yun-he, et al.
International Journal of Clinical and Experimental Pathology (2020) Vol. 13, Iss. 4, pp. 701-710
Closed Access | Times Cited: 41
Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression
Panxia Wang, Minghui Wang, Yuehuai Hu, et al.
Acta Pharmaceutica Sinica B (2020) Vol. 11, Iss. 3, pp. 680-693
Open Access | Times Cited: 41
TAZ promotes temozolomide resistance by upregulating MCL-1 in human glioma cells
Tian Tian, Aimin Li, Hong Lu, et al.
Biochemical and Biophysical Research Communications (2015) Vol. 463, Iss. 4, pp. 638-643
Closed Access | Times Cited: 49
Promoter methylation of yes-associated protein (YAP1) gene in polycystic ovary syndrome
Lile Jiang, Juanke Xie, Jinquan Cui, et al.
Medicine (2017) Vol. 96, Iss. 2, pp. e5768-e5768
Open Access | Times Cited: 46
The long noncoding RNA HOTAIR activates the Hippo pathway by directly binding to SAV1 in renal cell carcinoma
Guanghui Hu, Binbin Dong, Jingwei Zhang, et al.
Oncotarget (2017) Vol. 8, Iss. 35, pp. 58654-58667
Open Access | Times Cited: 44
Sphingosine-1-phosphate induces airway smooth muscle cell proliferation, migration, and contraction by modulating Hippo signaling effector YAP
Lu Liu, Cui Zhai, Yilin Pan, et al.
AJP Lung Cellular and Molecular Physiology (2018) Vol. 315, Iss. 4, pp. L609-L621
Open Access | Times Cited: 39
Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma
John M. Lamar, Vijeyaluxmy Motilal Nehru, Guy Weinberg
Cancers (2018) Vol. 10, Iss. 7, pp. 229-229
Open Access | Times Cited: 39
Page 1 - Next Page

Scroll to top